SO
VERA icon

STRS Ohio’s Vera Therapeutics VERA Stock Holding History

STRS Ohio’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$481K Buy
11,200
+5,000
+81% +$186K ﹤0.01% 1173
2026
Q1 		$249K Buy
+6,200
New +$267K ﹤0.01% 1395
2025
Q1 		– Sell
-1,800
Closed -$76.1K – 2026
2024
Q4 		$76.1K Sell
1,800
-2,100
-54% -$93K ﹤0.01% 1674
2024
Q3 		$172K Buy
3,900
+3,500
+875% +$133K ﹤0.01% 1595
2024
Q2 		$14.5K Sell
400
-1,500
-79% -$59.5K ﹤0.01% 1906
2024
Q1 		$81K Buy
1,900
+600
+46% +$21.4K ﹤0.01% 1708
2023
Q4 		$19K Buy
+1,300
New +$16.5K ﹤0.01% 1850
2022
Q4 		– Sell
-1,600
Closed -$34K – 2076
2022
Q3 		$34K Hold
1,600
– – ﹤0.01% 1880
2022
Q2 		$21K Hold
1,600
– – ﹤0.01% 1962
2022
Q1 		$37K Hold
1,600
– – ﹤0.01% 1984
2021
Q4 		$42K Hold
1,600
– – ﹤0.01% 2030
2021
Q3 		$27K Buy
+1,600
New +$28.6K ﹤0.01% 2158

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

STRS Ohio's VERA Position: Q2 2026 in Review

STRS Ohio increased its Vera Therapeutics (VERA) stake by 81% in Q2 2026, buying an estimated $186K and bringing the position to 11,200 shares worth $481K. The position accounts for ﹤0.01% of the portfolio, ranked #1173.

STRS Ohio first reported a position in VERA in Q3 2021 and has held it in 12 quarters since. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • STRS Ohio held 11,200 shares of Vera Therapeutics worth $481K as of Q2 2026.
  • STRS Ohio bought 5,000 Vera Therapeutics shares in Q2 2026, an estimated $186K.
  • Vera Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1173 holding.
  • STRS Ohio first reported a position in Vera Therapeutics in Q3 2021 and has held it in 12 quarters since.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.